Autor: Ales, A. - Prolib Integro

Skocz do pozycji: 1.

Tytuł:: Analytical models synthesis of power electronic converters
Autorzy:: Ales, A.
Cheurfi-Belhadj, M. A.
Schanen, J. L.
Moussaoui, D.
Roudet, J.
Tematy:: EMC modelling
differential mode
common mode
EMC filter
LISN
EMI
conducted noise
noise source; Pokaż więcej
Wydawca:: EEEIC International Barbara Leonowicz Szabłowska
Powiązania:: https://bibliotekanauki.pl/articles/136182.pdf Link otwiera się w nowym oknie
Opis:: In this paper we proposes a synthesis of different mathematical models of power electronic converters based on Thevenin/Norton equivalent circuits. Those models, composed by impedances and harmonic noise sources, are helpful to predict the conducted ElectroMagnetic Interferences (EMI) generated by converters connected to the electrical network. Moreover, the extracted impedances are determining for sizing EMC filters. The proposed analytical model is tested with PSpice simulations and validated by experimental measurements, from DC frequency until 30MHz.
Dostawca treści:: Biblioteka Nauki

Artykuł

na półce

Skocz do pozycji: 2.

Tytuł:: An international, expert-based, multispecialty Delphi Consensus document on stroke risk stratification and the optimal management of patients with asymptomatic and symptomatic carotid stenosis
Autorzy:: Zeebregts, Clark J. A. M.
Capoccia, Laura
Stoner, Michael C.
Gloviczki, Peter
Liapis, Christos D.
Reiff, Tilman
Farber, Mark A.
Secemsky, Eric A.
Spinelli, Francesco
Blinc, Ales
Svetlikov, Alexei
Uyttenboogaart, Maarten
Faggioli, Gianluca
Csobay-Novak, Csaba
Scali, Salvatore T.
Loftus, Ian M.
Poredos, Pavel
Fernandes e Fernandes, Jose
Gurevich, Victor S.
Eldrup-Jorgensen, Jens
Lyden, Sean P.
Nicolaides, Andrew N.
Erben, Young M.
Leal Lorenzo, Jose Ignacio
Thapar, Ankur
White, Christopher J.
Mansilha, Armando
Saba, Luca
Lanza, Gaetano
Shahidi, Saeid H.
Chaturvedi, Seemant
Schermerhorn, Marc L.
Setacci, Carlo
Jawien, Arkadiusz
Hicks, Caitlin W.
Clair, Daniel G.
Paraskevas, Kosmas I.
Jim, Jeffrey
Moore, Wesley S.
Malas, Mahmoud B.
Roubin, Gary S.
Sultan, Sherif A. H.
Dermody, Meghan
Perler, Bruce A.
Menyhei, Gabor
Conrad, Mark F.
Blecha, Matthew
Stilo, Francesco
Crupi, Domenica
Musiałek, Piotr
Silvestrini, Mauro
Di Lazzaro, Vincenzo
Schneider, Peter A.
Dardik, Alan
AbuRahma, Ali F.
D’Oria, Mario
Myrcha, Piotr
Abularrage, Christopher J.
Stone, David H.
Bulja, Deniz
Goudot, Guillaume
Proczka, Robert M.
de Borst, Gert J.
Dostawca treści:: Repozytorium Uniwersytetu Jagiellońskiego

Artykuł

na półce

Skocz do pozycji: 3.

Tytuł:: Introducing the special issues on consensus in Carotid Disease. Part 1 and Part 2.
Autorzy:: Wallace, Gabriel A.
Liapis, Christos D.
Dardik, Alan
Eldrup-Jorgensen, Jens
Gurevich, Victor
Saba, Luca
Menyhei, Gabor
Coelho, Andreia
DI Lazzaro, Vincenzo
Csobay-Novak, Csaba
Crupi, Domenica
Silvestrini, Mauro
Fernandes E Fernandes, Jose
Sultan, Sherif
Stoner, Michael C.
Mackevicius, Arturas
Pecoraro, Felice
Stilo, Francesco
Blinc, Ales
Lanza, Jessica
Thapar, Ankur
Malas, Mahmoud B.
Blecha, Matthew
Schneider, Peter A.
Spinelli, Francesco
Gloviczki, Peter
Sawicka, Agnieszka
Pitha, Jan
Casella, Ivan B.
Schermerhorn, Marc L.
Bruno, Antonino
Myrcha, Piotr
Faggioli, Gianluca
Eskandari, Mark K.
Jawien, Arkadiusz
Reiff, Tilman
Uyttenboogaart, Maarten
Migdalski, Arkadiusz
Loftus, Ian M.
Lip, Gregory Y.
Kashyap, Vikram S.
Erben, Young M.
Paraskevas, Kosmas I.
Setacci, Carlo
Lal, Brajesh K.
Stone, David H.
Davies, Alun H.
Poredos, Pavel
Mansilha, Armando
Mikhailidis, Dimitri P.
Nicolaides, Andrew N.
Perler, Bruce A.
Pini, Rodolfo
White, Christopher J.
Lyden, Sean P.
Spinetti, Gaia
Bruno, Salvatore
Chaturvedi, Seemant
Lanza, Gaetano
Musiałek, Piotr
Secemsky, Eric A.
Dermody, Meghan
Aburahma, Ali F.
Zeebregts, Clark J.
Svetlikov, Alexei
Setacci, Francesco
Abularrage, Christopher J.
D'Oria, Mario
Dostawca treści:: Repozytorium Uniwersytetu Jagiellońskiego

Artykuł

na półce

Skocz do pozycji: 4.

Autorzy:: Mikhailidis, Dimitri P.
Lip, Gregory Y.
Liapis, Christos D.
D'Oria, Mario
Gargiulo, Mauro
Reiff, Tilman
Spinelli, Francesco
Blinc, Ales
Svetlikov, Alexei
Sawicka, Agnieszka
Uyttenboogaart, Maarten
Nicolaides, Andrew
Gurevich, Victor
Davies, Alun H.
Gloviczki , Peter
Poredos, Pavel
Spinetti, Gaia
Eldrup-Jorgensen, Jens
Erben, Young M.
Thapar, Ankur
White, Christopher J.
Chaturvedi, Seemant
Saba, Luca
Sufali, Gemmi
Lanza, Gaetano
Schermerhorn, Marc L.
Mansilha, Armando
Setacci, Carlo
Jawien, Arkadiusz
Aburahma, Ali F.
Paraskevas, Kosmas I.
Sultan, Sherif A.
Moore, Wesley S.
Malas, Mahmoud B.
Perler, Bruce A.
Blecha, Matthew
Bruno, Antonino
Stilo, Francesco
Musiałek, Piotr
Meschia, James F.
Silvestrini, Mauro
Di Lazzaro, Vincenzo
Dardik, Alan
Zeebregts, Clark J.
Myrcha, Piotr
Schneider, Peter M.
Lyden, Sean P.
Dostawca treści:: Repozytorium Uniwersytetu Jagiellońskiego

Artykuł

na półce

Skocz do pozycji: 5.

Tytuł:: Frequency and prognostic impact of ALK amplifications and mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1)
Autorzy:: Popovic-Beck, Maja
Bown, Nick
Font de Mora, Jaime
Noguera, Rosa
Taschner-Mandl, Sabine
Muhlethaler-Mottet, Annick
Laureys, Genevieve
Malis, Josef
Pierron, Gaelle
Kogner, Per
Rossing, Maria
Combaret, Valerie
Chesler, Louis
Castel, Victoria
Luksch, Roberto
Tweddle, Deborah A.
Bellini, Angela
de Preter, Katleen
Ladenstein, Ruth
George, Sally L.
Ambros, Peter F.
Baulande, Sylvain
Beiske, Klaus
Marques, Barbara
Ash, Shifra
Clement, Nathalie
van Roy, Nadine
Valteau-Couanet, Dominique
Balwierz, Walentyna
Schleiermacher, Gudrun
Martinsson, Tommy
Vicha, Ales
Delattre, Olivier
Auger, Nathalie
Jeison, Marta
Morini, Martina
Betts, David R.
Bhalshankar, Jaydutt
Lapouble, Eve
Elliott, Martin
Bernkopf, Marie
Mazzocco, Katia
Potschger, Ulrike
Bernard, Virginie
Jimenez, Irene
Opis:: Purpose: In neuroblastoma (NB), the ALK receptor tyrosine kinase can be constitutively activated through activating point mutations or genomic amplification. We studied ALK genetic alterations in high-risk (HR) patients on the HR-NBL1/SIOPEN trial to determine their frequency, correlation with clinical parameters, and prognostic impact. Materials and Methods: Diagnostic tumor samples were available from 1,092 HR-NBL1/SIOPEN patients to determine ALK amplification status (n = 330), ALK mutational profile (n = 191), or both (n = 571). Results: Genomic ALK amplification (ALKa) was detected in 4.5% of cases (41 out of 901), all except one with MYCN amplification (MNA). ALKa was associated with a significantly poorer overall survival (OS) (5-year OS: ALKa [n = 41] 28% [95% CI, 15 to 42]; no-ALKa [n = 860] 51% [95% CI, 47 to 54], [P < .001]), particularly in cases with metastatic disease. ALK mutations (ALKm) were detected at a clonal level (> 20% mutated allele fraction) in 10% of cases (76 out of 762) and at a subclonal level (mutated allele fraction 0.1%-20%) in 3.9% of patients (30 out of 762), with a strong correlation between the presence of ALKm and MNA (P < .001). Among 571 cases with known ALKa and ALKm status, a statistically significant difference in OS was observed between cases with ALKa or clonal ALKm versus subclonal ALKm or no ALK alterations (5-year OS: ALKa [n = 19], 26% [95% CI, 10 to 47], clonal ALKm [n = 65] 33% [95% CI, 21 to 44], subclonal ALKm (n = 22) 48% [95% CI, 26 to 67], and no alteration [n = 465], 51% [95% CI, 46 to 55], respectively; P = .001). Importantly, in a multivariate model, involvement of more than one metastatic compartment (hazard ratio [HR], 2.87; P < .001), ALKa (HR, 2.38; P = .004), and clonal ALKm (HR, 1.77; P = .001) were independent predictors of poor outcome. Conclusion: Genetic alterations of ALK (clonal mutations and amplifications) in HR-NB are independent predictors of poorer survival. These data provide a rationale for integration of ALK inhibitors in upfront treatment of HR-NB with ALK alterations.
Dostawca treści:: Repozytorium Uniwersytetu Jagiellońskiego